BAUSCH + LOMB CORP(NYSE:BLCO) stock News

BLCO Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

9 days ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

2 months ago - By: The Motley Fool

Bausch Lomb (BLCO) Q2 Revenue Rises 5%

10 days ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States

2 months ago - By: Benzinga - Mentions: ALL ZIMV NEU LRCX ...

Earnings Scheduled For July 30, 2025

2 months ago - By: Benzinga

Examining the Future: Bausch & Lomb's Earnings Outlook

a month ago - By: Yahoo Finance - Mentions: BHC

Icahn representations resign Bausch + Lomb board after agreement termination

a month ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Board Changes

a month ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb to Participate in Upcoming Investor Conferences

2 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Second-Quarter 2025 Results

2 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops

3 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye

3 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13

3 months ago - By: Bragar Eagel & Squire

BAUSCH & LOMB ALERT: Bragar Eagel & Squire, P.C. is Investigating Bausch + Lomb Corporation on Behalf of Bausch & Lomb Stockholders and Encourages Investors to Contact the Firm

3 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility

3 months ago - By: The Law Offices of Frank R. Cruz

Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

3 months ago - By: Law Offices of Howard G. Smith

Bausch + Lomb Corporation (BLCO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

3 months ago - By: Yahoo Finance - Mentions: BHC

Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June

3 months ago - By: Glancy Prongay & Murray LLP

Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

3 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering

3 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

BAUSCH + LOMB CORP (BLCO) Stock News

BLCO Latest News, Press Relases and Analysis

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

Bausch Lomb (BLCO) Q2 Revenue Rises 5%

Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States

Earnings Scheduled For July 30, 2025

Examining the Future: Bausch & Lomb's Earnings Outlook

Icahn representations resign Bausch + Lomb board after agreement termination

Bausch + Lomb Announces Board Changes

Bausch + Lomb to Participate in Upcoming Investor Conferences

Bausch + Lomb Announces Second-Quarter 2025 Results

Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops

Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye

Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13

BAUSCH & LOMB ALERT: Bragar Eagel & Squire, P.C. is Investigating Bausch + Lomb Corporation on Behalf of Bausch & Lomb Stockholders and Encourages Investors to Contact the Firm

Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility

Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Bausch + Lomb Corporation (BLCO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June

Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering

Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement